UCB's Global Corporate Website
Welcome to UCB in the United States

Sep

30

Leaving a Legacy: Alicia Clark Inspires this Hispanic Heritage Month

This Hispanic Heritage Month, we are showcasing the story of Alicia Clark, District Sales Lead, Rheumatology, as it is an inspiration to those around her both inside and outside UCB.

Sep

29

New Bimekizumab Two-Year Data in Moderate to Severe Plaque Psoriasis Presented at the 30th European Academy of Dermatology and Venereology Congress

Sep

27

The Art of Being Data-Enabled: UCB’s Approach to Delivering Innovative Patient Solutions

Sep

21

Connecting Data Insights to Patient Impacts: Imagining the Future of UCB’s Digital Business Transformation (DBT)

Kim Moran, UCB’s U.S. Head of Insights to Impact, is dedicated to UCB’s overall mission of creating value for people living with severe diseases. With an extensive knowledge of data and science, gained during her 14 years at UCB, Kim has put her ability to glean insights from available data to develop solutions that seek to improve the lives of people living with severe diseases.

Sep

07

Our R&D Response to COVID-19: A Patients’ First Approach

UCB’s robust global R&D response during COVID-19 focused on our patients, employees, and our communities. Read more on our overall approach from UCB's Chief Medical Officer, Iris Loew-Friedrich.  

Sep

01

UCB’s Commitment to Students Living with Epilepsy

Each year, UCB has the honor of awarding our UCB Family Epilepsy Scholarship to deserving individuals living with epilepsy, their family members, and caregivers to help them fulfill their dreams. We realize that to truly make an impact on patients’ lives, we must go beyond developing and delivering medicines, and we are committed to helping patients and their families receive the financial support they need to live their best lives possible.